![Omicron: Is the light at the end of the tunnel (a) pandemic salvation, or (b) an oncoming freight train?](https://cdn.cancerletter.com/media/2022/01/14172003/48-02-omicron-4x3-1.jpg)
![Omicron: Is the light at the end of the tunnel (a) pandemic salvation, or (b) an oncoming freight train?](https://cdn.cancerletter.com/media/2022/01/14172003/48-02-omicron-4x3-1.jpg)
Cover Story
COVID-19 & CancerGuest Editorial
By Jeremy L. Warner and Sanjay Mishra
As we head into the third year of the global COVID-19 pandemic, everyone would just like it to be over.
COVID-19 & Cancer
By Matthew Bin Han Ong, Alexandria Carolan and Alice Tracey
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Clinical Roundup
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
Drugs & Targets
Trending Stories
- When tobacco companies sponsored the Olympics
- U.S. News rankings for cancer hospitals shift again with inclusion of Medicare Advantage data
Rankings now include a list of Best Regional Hospitals for Equitable Access - How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Kamala Harris widely expected to continue Cancer Moonshot; Conservatives present their vision in Project 2025
- Cancer Moonshot contributes additional $100M to reduce cancer burden in Africa
- Robert Gallo named founding director of Microbial Oncology Program at TGH Cancer Institute